Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ibandronate vs IV Zoledronate in Metastatic Breast Cancer
NCT00301886Phase 3Withdrawn
- Sponsor
- SWOG Cancer Research Network
- Start
- May 2006
- Primary completion
- May 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ibandronate in bone metastases, sponsored by SWOG Cancer Research Network. Planned start May 2006; status: withdrawn.
02
Drugs
ibandronate
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00301886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301886.